{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:23:36Z","timestamp":1792787016311,"version":"4.5.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2017,11,3]],"date-time":"2017-11-03T00:00:00Z","timestamp":1509667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Rare Diseases Translational Research Collaboration"},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1,8]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>Immunoglobulin replacement therapy enhances survival and reduces infection risk in patients with agammaglobulinaemia. We hypothesized that despite regular immunoglobulin therapy, some patients will experience ongoing respiratory infections and develop progressive bronchiectasis with deteriorating lung function. One hundred and thirty-nine (70%) of 199 patients aged 1\u201380 years from nine cities in the United Kingdom with agammaglobulinaemia currently listed on the UK Primary Immune Deficiency (UKPID) registry were recruited into this retrospective case study and their clinical and laboratory features analysed; 94% were male, 78% of whom had Bruton tyrosine kinase (BTK) gene mutations. All patients were on immunoglobulin replacement therapy and 52% had commenced therapy by the time they were 2 years old. Sixty per cent were also taking prophylactic oral antibiotics; 56% of patients had radiological evidence of bronchiectasis, which developed between the ages of 7 and 45 years. Multivariate analysis showed that three factors were associated significantly with bronchiectasis: reaching 18 years old [relative risk (RR) = 14\u00b72, 95% confidence interval (CI) = 2\u00b77\u201374\u00b76], history of pneumonia (RR = 3\u00b79, 95% CI = 1\u00b71\u201313\u00b78) and intravenous immunoglobulin (IVIG) rather than subcutaneous immunoglobulin (SCIG) = (RR = 3\u00b75, 95% CI = 1\u00b72\u201310\u00b71), while starting immunoglobulin replacement after reaching 2 years of age, gender and recent serum IgG concentration were not associated significantly. Independent of age, patients with bronchiectasis had significantly poorer lung function [predicted forced expiratory volume in 1 s 74% (50\u201391)] than those without this complication [92% (84\u2013101)] (P &amp;lt; 0\u00b7001). We conclude that despite immunoglobulin replacement therapy, many patients with agammaglobulinaemia can develop chronic lung disease and progressive impairment of lung function.<\/jats:p>","DOI":"10.1111\/cei.13068","type":"journal-article","created":{"date-parts":[[2017,10,9]],"date-time":"2017-10-09T05:47:01Z","timestamp":1507528021000},"page":"212-219","source":"Crossref","is-referenced-by-count":34,"title":["Bronchiectasis and deteriorating lung function in agammaglobulinaemia despite immunoglobulin replacement therapy"],"prefix":"10.1093","volume":"191","author":[{"given":"A","family":"Stubbs","sequence":"first","affiliation":[{"name":"Paediatric Allergy and Immunology, University of Manchester, Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Bangs","sequence":"additional","affiliation":[{"name":"Paediatric Allergy and Immunology, University of Manchester, Manchester, Manchester, UK"},{"name":"UKPIN UKPID Registry Team, UKPIN, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Shillitoe","sequence":"additional","affiliation":[{"name":"Department of Immunology, Great Northern Children's Hospital, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J D","family":"Edgar","sequence":"additional","affiliation":[{"name":"UKPIN UKPID Registry Team, UKPIN, London, UK"},{"name":"Regional Immunology Service, The Royal Hospitals, Belfast, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S O","family":"Burns","sequence":"additional","affiliation":[{"name":"Department of Immunology, Royal Free Hospital, Institute of Immunology and Transplantation, University College, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Thomas","sequence":"additional","affiliation":[{"name":"Immunology, NHS Greater Glasgow & Clyde, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Alachkar","sequence":"additional","affiliation":[{"name":"Immunology, Salford Royal Foundation Trust, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5646-4707","authenticated-orcid":false,"given":"M","family":"Buckland","sequence":"additional","affiliation":[{"name":"UKPIN UKPID Registry Team, UKPIN, London, UK"},{"name":"Immunology, St Bartholomew's Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"McDermott","sequence":"additional","affiliation":[{"name":"Immunology, Queens Medical Centre, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Arumugakani","sequence":"additional","affiliation":[{"name":"Department of Immunology, University of Leeds, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M S","family":"Jolles","sequence":"additional","affiliation":[{"name":"Department of Immunology, University Hospital of Wales, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Herriot","sequence":"additional","affiliation":[{"name":"Immunology, Aberdeen Royal Infirmary, Aberdeen, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7411-5375","authenticated-orcid":false,"given":"P D","family":"Arkwright","sequence":"additional","affiliation":[{"name":"Paediatric Allergy and Immunology, University of Manchester, Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,11,3]]},"reference":[{"key":"2021120808192146200_cei13068-bib-0001","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/361226a0","article-title":"The gene involved in X-linked agammaglobulinaemia is a member of the SRC family of protein-tyrosine kinases","volume":"361","author":"Vetrie","year":"1993","journal-title":"Nature"},{"key":"2021120808192146200_cei13068-bib-0002","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1146\/annurev.immunol.021908.132649","article-title":"Primary B cell immunodeficiencies: comparisons and contrasts","volume":"27","author":"Conley","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"2021120808192146200_cei13068-bib-0003","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1056\/NEJM199611143352003","article-title":"Mutations in the mu heavy-chain gene in patients with agammaglobulinemia","volume":"335","author":"Yel","year":"1996","journal-title":"N Engl J Med"},{"key":"2021120808192146200_cei13068-bib-0004","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1084\/jem.187.1.71","article-title":"Mutations in the human lambda5\/14.1 gene result in B cell deficiency and agammaglobulinemia","volume":"187","author":"Minegishi","year":"1998","journal-title":"J Exp Med"},{"key":"2021120808192146200_cei13068-bib-0005","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1126\/science.286.5446.1954","article-title":"An essential role for BLNK in human B cell development","volume":"286","author":"Minegishi","year":"1999","journal-title":"Science"},{"key":"2021120808192146200_cei13068-bib-0006","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1172\/JCI7696","article-title":"Mutations in Igalpha (CD79a) result in a complete block in B-cell development","volume":"104","author":"Minegishi","year":"1999","journal-title":"J Clin Invest"},{"key":"2021120808192146200_cei13068-bib-0007","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.aller.2010.12.003","article-title":"Pulmonary complications in patients with antibody deficiency","volume":"39","author":"Costa-Carvalho","year":"2011","journal-title":"Allergol Immunopathol (Madr)"},{"key":"2021120808192146200_cei13068-bib-0008","first-page":"122","article-title":"Evaluation of pulmonary complications in patients with primary immunodeficiency disorders","volume":"49","author":"Reisi","year":"2017","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"2021120808192146200_cei13068-bib-0009","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1542\/peds.9.6.722","article-title":"Agammaglobulinemia","volume":"9","author":"Bruton","year":"1952","journal-title":"Pediatrics"},{"key":"2021120808192146200_cei13068-bib-0010","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1440-1843.2009.01679.x","article-title":"Comparison of pulmonary diseases in common variable immunodeficiency and X-linked agammaglobulinaemia","volume":"15","author":"Aghamohammadi","year":"2010","journal-title":"Respirology"},{"key":"2021120808192146200_cei13068-bib-0011","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/cei.12748","article-title":"Clinical and laboratory correlates of lung disease and cancer in adults with idiopathic hypogammaglobulinaemia","volume":"184","author":"Brent","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"2021120808192146200_cei13068-bib-0012","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaci.2013.12.1077","article-title":"Clinical picture and treatment of 2212 patients with common variable immunodeficiency","volume":"134","author":"Gathmann","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"2021120808192146200_cei13068-bib-0013","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S2213-2600(15)00202-7","article-title":"Lung disease in primary antibody deficiency","volume":"3","author":"Verma","year":"2015","journal-title":"Lancet Respir Med"},{"key":"2021120808192146200_cei13068-bib-0014","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.anai.2010.04.015","article-title":"Development of pulmonary abnormalities in patients with common variable immunodeficiency: associations with clinical and immunologic factors","volume":"104","author":"Gregersen","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2021120808192146200_cei13068-bib-0015","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0009-9260(05)80501-X","article-title":"Bronchiectasis in hypogammaglobulinaemia\u2013a computed tomography assessment","volume":"44","author":"Curtin","year":"1991","journal-title":"Clin Radiol"},{"key":"2021120808192146200_cei13068-bib-0016","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0091-6749(99)70085-0","article-title":"Pulmonary abnormalities in patients with primary hypogammaglobulinemia","volume":"104","author":"Kainulainen","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"2021120808192146200_cei13068-bib-0017","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1056\/NEJM195502172520703","article-title":"Agammaglobulinemia and bronchiectasis; a report of two cases in adults, with autopsy findings","volume":"252","author":"Collins","year":"1955","journal-title":"N Engl J Med"},{"key":"2021120808192146200_cei13068-bib-0018","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jaci.2016.11.050","article-title":"IgG trough levels and progression of pulmonary disease in pediatric and adult common variable immunodeficiency disorder patients","volume":"140","author":"Janssen","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"2021120808192146200_cei13068-bib-0019","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/cei.12172","article-title":"The United Kingdom Primary Immune Deficiency (UKPID) Registry: report of the first 4 years' activity 2008\u20132012","volume":"175","author":"Edgar","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"2021120808192146200_cei13068-bib-0020","doi-asserted-by":"crossref","first-page":"e4544","DOI":"10.1097\/MD.0000000000004544","article-title":"Clinical characteristics and genetic profiles of 174 patients with X-linked agammaglobulinemia: report from Shanghai, China (2000\u20132015)","volume":"95","author":"Chen","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"2021120808192146200_cei13068-bib-0021","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1016\/j.molimm.2009.03.012","article-title":"Genetic and demographic features of X-linked agammaglobulinemia in Eastern and Central Europe: a cohort study","volume":"46","author":"T\u00f3th","year":"2009","journal-title":"Mol Immunol"},{"key":"2021120808192146200_cei13068-bib-0022","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0091-6749(91)90306-9","article-title":"Retrospective analysis of the incidence of pulmonary disease in hypogammaglobulinemia","volume":"88","author":"Sweinberg","year":"1991","journal-title":"J Allergy Clin Immunol"},{"key":"2021120808192146200_cei13068-bib-0023","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.jaci.2010.02.040","article-title":"Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years","volume":"125","author":"Lucas","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"2021120808192146200_cei13068-bib-0024","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.anai.2014.04.024","article-title":"Pulmonary radiologic findings in common variable immunodeficiency: clinical and immunological correlations","volume":"113","author":"Maglione","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2021120808192146200_cei13068-bib-0025","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/s10875-014-0068-6","article-title":"CT screening for pulmonary pathology in common variable immunodeficiency disorders and the correlation with clinical and immunological parameters","volume":"34","author":"Maarschalk-Ellerbroek","year":"2014","journal-title":"J Clin Immunol"},{"key":"2021120808192146200_cei13068-bib-0026","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s10875-016-0284-3","article-title":"Respiratory health and related quality of life in patients with congenital agammaglobulinemia in the northern region of the UK","volume":"36","author":"Bryan","year":"2016","journal-title":"J Clin Immunol"},{"key":"2021120808192146200_cei13068-bib-0027","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s10875-017-0379-5","article-title":"Serial serum immunoglobulin G (IgG) trough levels in patients with X-linked agammaglobulinemia on replacement therapy with intravenous immunoglobulin: its correlation with infections in Indian children","volume":"37","author":"Suri","year":"2017","journal-title":"J Clin Immunol"},{"key":"2021120808192146200_cei13068-bib-0028","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10875-011-9511-0","article-title":"Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a multicenter prospective cohort study","volume":"31","author":"Quinti","year":"2011","journal-title":"J Clin Immunol"},{"key":"2021120808192146200_cei13068-bib-0029","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.clim.2010.06.012","article-title":"Impact of trough IgG on pneumonia incidence in primary immunodeficiency: a meta-analysis of clinical studies","volume":"137","author":"Orange","year":"2010","journal-title":"Clin Immunol"},{"key":"2021120808192146200_cei13068-bib-0030","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2147\/PPA.S60771","article-title":"Improving current immunoglobulin therapy for patients with primary immunodeficiency: quality of life and views on treatment","volume":"8","author":"Espanol","year":"2014","journal-title":"Patient Prefer Adherence"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcei.13068","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/191\/2\/212\/41644446\/cei13068.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/191\/2\/212\/41644446\/cei13068.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T23:26:08Z","timestamp":1659569168000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/191\/2\/212\/6412321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,3]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,11,3]]},"published-print":{"date-parts":[[2018,1,8]]}},"URL":"https:\/\/doi.org\/10.1111\/cei.13068","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,2]]},"published":{"date-parts":[[2017,11,3]]}}}